The virulence variability of different Acinetobacter baumannii strains in experimental pneumonia

Journal of Infection

Volumn 60, Issue 2, 2010, Pages 154-161

  Eveillard, Matthieu ^a,b   Soltner, Christophe ^a,b   Kempf, Marie ^a,b   Saint André, Jean Paul ^a,b   Lemarié, Carole ^b   Randrianarivelo, Catherine ^b   Seifert, Harald ^c   Wolff, Michel ^d   Joly Guillou, Marie Laure ^a,b  

^a UNIVERSITÉ D'ANGERS   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY OF COLOGNE   (Germany)

^d BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; MACROPHAGE INFLAMMATORY PROTEIN 2; MINOCYCLINE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TICARCILLIN; TIMENTIN; TUMOR NECROSIS FACTOR ALPHA;

ACINETOBACTER BAUMANNII; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIAL PNEUMONIA; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BODY WEIGHT; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; MICROBIAL ACTIVITY; MORTALITY; MOUSE; NONHUMAN; PATHOGENESIS;

EID: 75549083168     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2009.09.004     Document Type: Article

References (35)

1. Falagas M.E., Karveli E.A., Kelesidis I., Kelesidis T. Community-acquired Acinetobacter infections. Eur J Clin Microbiol Infect Dis 2007, 26:857-868.
2. Joly-Guillou M.L. Clinical impact and pathogenicity of Acinetobacter. Clin Microbiol Infect 2005, 11:868-873.
3. Garnacho J., Sole-Violan J., Sa-Borges M., Diaz E., Rello J. Clinical impact of pneumonia caused by Acinetobacter baumannii in intubated patients: a matched cohort study. Crit Care Med 2003, 31:2478-2482.
4. Lortholary O., Fagon J.-Y., Buu-Hoi A., Slama M.A., Pierre J., Giral P., et al. Nosocomial acquisition of multiresistant Acinetobacter baumannii: risk factors and prognosis. Clin Infect Dis 1995, 20:790-796.
5. Gaynes R., Edwards J.R. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 2005, 41:848-854.
6. Calhoun J.H., Murray C.K., Manring M.M. Multidrug-resistant organisms in military wounds from Iraq and Afghanistan. Clin Orthop Relat Res 2008, 466:1356-1362.
7. Oncül O., Keskin O., Acar H.V., et al. Hospital-acquired infections following the 1999 Marmara earthquake. J Hosp Infect 1999, 51:47-51.
8. Sebeny P.J., Riddle M.S., Petersen K. Acinetobacter baumannii skin and soft-tissue infection associated with war trauma. Clin Infect Dis 2008, 47:444-449.
9. Garzoni C., Emonet S., Legout L., Benedict R., Hoffmeyer P., Bernard L., et al. Atypical infections in tsunami survivors. Emerg Infect Dis 2005, 11:1591-1593.
10. Markogiannakis A., Fildisis G., Tsiplakou S., Ikonomidis A., Koutsoukou A., Pournaras S., et al. Cross-transmission of multidrug-resistant Acinetobacter baumannii clonal strains causing episodes of sepsis in a trauma intensive care unit. Infect Control Hosp Epidemiol 2008, 29:410-417.
11. Naas T., Coignard B., Carbonne A., Blankaert K., Bajolet O., Bernet C., et al. VEB-1 extended-spectrum β-lactamase-producing Acinetobacter baumannii, France. Emerg Infect Dis 2006, 12:1214-1222. on behalf of the French Nosocomial Infection Early Warning, Investigation and Surveillance NetworkInvestigation and Surveillance Network.
12. Zanetti G., Blanc D.S., Federli I., Raffoul W., Petignat C., Maravic P., et al. Importation of Acinetobacter baumannii into a burn unit: a recurrent outbreak of infection associated with widespread environmental contamination. Infect Control Hosp Epidemiol 2007, 28:723-725.
13. Marchaim D., Navon-Venezia S., Schwartz D., Tarabeia J., Fefer I., Schwaber M.J., et al. Surveillance cultures and duration of carriage of multidrug-resistant Acinetobacter baumannii. J Clin Microbiol 2007, 45:1551-1555.
14. Richet H., Fournier P.E. Nosocomial infections caused by Acinetobacter baumannii: a major threat worldwide. Infect Control Hosp Epidemiol 2006, 27:645-646.
15. Bergogne-Bérézin E., Towner K.J. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical and epidemiological features. Clin Microbiol Rev 1996, 9:148-165.
16. Shih M.-J., Lee N.Y., Lee H.C., Chang C.M., Wu C.J., Chen P.L., et al. Risk factors of multidrug resistance in nosocomial bacteremia due to Acinetobacter baumannii: a case-control study. J Microbiol Immunol Infect 2008, 14:118-123.
17. Gkrawia-Klostas E., Hershow R.C. Colonization or infection with multidrug-resistant Acinetobacter baumannii may be an independent risk factor for increased mortality. Clin Infect Dis 2006, 43:1224-1225.
18. Lee N.-Y., Lee H.C., Ko N.Y., Chang C.M., Shih H.I., Wu C.J., et al. Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia. Infect Control Hosp Epidemiol 2007, 28:713-719.
19. Wroblewska M.M., Sawicka-Grzelak A., Marchel H., Luczak M., Sivan A. Biofilm production by clinical strains of Acinetobacter baumannii isolated from patients hospitalized in two tertiary-care hospitals. FEMS Immunol Med Microbiol 2008, 53:140-144.
20. Joly-Guillou M.-L., Wolff M., Pocidalo J.-J., Walker F., Carbon C. Use of a new mouse model of Acinetobacter baumannii pneumonia to evaluate the postantibiotic effect of imipenem. Antimicrob Agent Chemother 1997, 41:345-351.
21. Seifert H., Richter W., Pulverer G. Clinical and bacteriological features of relapsing shunt-associated meningitides due to Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis 1995, 14:130-134.
22. Turton J.F., Kaufmann M.E., Warner M., Coelho J., Dijkshoorm L., van der Reijden T., et al. A prevalent, multiresistant, clone of Acinetobacter baumannii in South East England. J Hosp Infect 2004, 58:170-179.
23. van Faassen H., KuoLee R., Harris G., Zhao X., Conlan J.W., Chen W. Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice. Infect Immun 2007, 75:5597-5608.
24. Anstey N.M., Currie B.J., Withnall K.H. Community-acquired Acinetobacter pneumonia in the northern territory of Australia. Clin Infect Dis 1992, 14:83-91.
25. Yang C.H., Chen K.J., Wang C.K. Community-acquired Acinetobacter pneumonia: a case report. J Infect 1997, 35:316-318.
26. Ilan O., Bloch Y., Frankel G., Ullrich H., Geider K., Rosenhime I. Protein tyrosine kinases in bacterial pathogens are associated with virulence and production of exopolysaccharide. EMBO J 1999, 18:3241-3248.
27. Obana Y. Pathogenic significance of Acinetobacter calcoaceticus: analysis of experimental infection in mice. Microbiol Immunol 1986, 30:645-657.
28. Gaddy J.A., Actis L.A. Regulation of Acinetobacter baumannii biofilm formation. Future microbiology 2009, 4:273-278.
29. Adams M.D., Goglin K., Molyneaux N., Hujer K.M., Lavender H., Jamisson J.J., et al. Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii. J Bacteriol 2008, 190:8053-8064.
30. Dehoux M.S., Boutten A., Ostinelli J., Seta N., Dombret M.C., Crestani B., et al. Compartimentalized cytokine production within the human lung in unilateral pneumonia. Am J Respir Crit Care Med 1994, 150:710-716.
31. Bergeron Y., Ouellet N., Deslauriers A., Simard M., Olivier M., Bergeron M.G. Cytokine kinetics and other factors in response to pneumococcal pulmonary infection in mice. Infect Immun 1998, 66:912-922.
32. Russo T.A., Beanan J.M., Olson R., MacDonald U., Luke N.R., Gill S.R., et al. Rat pneumonia and soft-tissue infection models for the study of Acinetobacter baumannii biology. Infect Immun 2008, 76:3577-3586.
33. Mohler J., Azoulay-Dupuis E., Amory-Rivier C., Mazoit J.X., Bédos J.P., Rieux V., et al. Streptococcus pneumoniae strain-dependent lung inflammatory responses in a murine model of pneumococcal pneumonia. Intens Care Med 2003, 29:808-816.
34. Ramos C.D.L., Fernandes K.S.S., Canetti C., Texeira M.M., Silva J.S., Cunha F.Q. Neutrophil recruitment in immunized mice depends on MIP-2 inducing the sequential release of MIP-1∞, TNF-∞, and LTB4. Eur J Immunol 2006, 36:2015-2034.
35. Smith M.G., Gianoulis T.A., Putatzki S., Mekalanos J.J., Ornston L.N., Gerstein M., et al. New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev 2007, 21:601-614.